Widgets for Webmasters
PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet
genengnews.com 6 hrs ago 3 relatedEUREKALERT Contact: Jane Baj jbaj@ptcbio.com 1 of the first therapies to address the underlying cause of cystic fibrosis; oral drug may represent new treatment paradigm SOUTH PLAINFIELD, NJ August 20, 2008 New phase 2 data...

